U.S. Markets closed
  • S&P 500

    3,699.12
    +32.40 (+0.88%)
     
  • Dow 30

    30,218.26
    +248.74 (+0.83%)
     
  • Nasdaq

    12,464.23
    +87.05 (+0.70%)
     
  • Russell 2000

    1,892.45
    +43.75 (+2.37%)
     
  • Crude Oil

    46.04
    +0.40 (+0.88%)
     
  • Gold

    1,840.70
    -0.40 (-0.02%)
     
  • Silver

    24.28
    +0.15 (+0.61%)
     
  • EUR/USD

    1.2124
    -0.0025 (-0.2061%)
     
  • 10-Yr Bond

    0.9690
    +0.0490 (+5.33%)
     
  • Vix

    20.66
    -0.62 (-2.91%)
     
  • GBP/USD

    1.3430
    -0.0023 (-0.1679%)
     
  • USD/JPY

    104.1550
    +0.2950 (+0.2840%)
     
  • BTC-USD

    18,910.06
    -47.96 (-0.25%)
     
  • CMC Crypto 200

    370.44
    -8.81 (-2.32%)
     
  • FTSE 100

    6,550.23
    +59.96 (+0.92%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Johnson & Johnson to Participate in the 9th Annual SVB Leerink Global Healthcare Conference

·1 min read

NEW BRUNSWICK, N.J., Feb. 12, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, Feb. 26th, at Lotte New York Palace, NY. Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 2:00 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately two hours after the live webcast.

(PRNewsfoto/Johnson & Johnson)
(PRNewsfoto/Johnson & Johnson)
Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-9th-annual-svb-leerink-global-healthcare-conference-301004093.html

SOURCE Johnson & Johnson